32
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Increased Serum Soluble Fas Ligand Associated with Recurrent B-Cell Non-Hodgkin's Lymphoma after Autologous Peripheral Blood Stem Cell Transplantation

, , , , , , , , , , , , , , , , & show all
Pages 625-628 | Accepted 18 Nov 1998, Published online: 01 Jul 2009

References

  • Nagata S., Goldstein P. The Fas death factor. Science 1995; 267: 1449–1456
  • Kayagaki N., Kawasaki A., Ebata T., Ohmoto H., Ikeda S., Inoue S., Yoshino K., Okumura K., Yagita H. Metalloproteinase‐mediated release of human Fas ligand. Journal of Experimental Medicine 1995; 182: 1777–1783
  • Tanaka M., Suda X., Haze K., Nakamura N., Sato K., Kimura F., Motoyoshi K., Mizuki M., Tagawa S., Ohga S., Hatake K., Drummond A. H., Nagata S. Fas ligand in human serum. Nature Medicine 1996; 2: 317–322
  • Sato K., Kimura F., Nakamura Y., Murakami H., Yoshida M., Tanaka M., Nagata S., Kanatani Y., Wakimoto N., Nagata N., Motoyoshi K. An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. British Journal of Haematology 1996; 94: 379–382
  • Kanda Y., Tanaka Y., Shirakawa K., Yatomi T., Nakamura N., Kami M., Saito T., Izutsu K., Asai T., Yuji K., Ogawa S., Honda H., Mitani K., Chiba S., Yazaki Y., Hirai H. Increased soluble Fas‐ligand in sera of bone mmow transplant recipients with acute graft‐versus‐host di‐ sease. Bone Marrow Transplantation 1998; 22: 751–754
  • Hahne M., Rimoldi D., Schrijter M., Romero P., Schreier M., French L. E., Schneider P., Bornand T., Fontana A., Lienard D., Cerottini J. C., Tschopp J. Melanoma cell expression of Fas (Apo‐1/CD95) ligand: Implications for tumor immune escape. Science 1996a; 274: 1363–1366
  • Strand S., Hofmann W. J., Hug H., Müller M., Otto G., Strand D., Mariani S. M., Stremmel W., Krammer P. H., Galle P. R. Lymphocyte apotosis induced by CD95 (Apo‐ Was) ligand‐expressing tumor cells ‐ A mechanism of immune evasion?. Nature Medicine 1996; 2: 1361–1366
  • Xem L., Devilard E., Hassoun J., Haddad P., Birg F. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas‐mediated apoptosis. Leukemia 1997; 11: 1868–1877
  • Tanaka M., Itai X., Adachi M., Nagata S. Down‐regulation of Fas ligand by shedding. Nature Medicine 1998; 4: 31–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.